Clinical Trial Update: A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports that Diamyd is being studied in newly diagnosed Type 1 diabetes to assess preservation of insulin production and glycemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Diamyd

Snippet

Sponsor: Diamyd Medical AB | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: ACTIVE_NOT_RECRUITING